Several directors of GlaxoSmithKline offloaded shares in the healthcare giant on Tuesday in order to meet certain tax liabilities. GSK chief executive Emma Walmsley disposed of 5,868 ordinary shares at 1,312.63p a piece for a total of £77,201.17, while chief financial officer Simon Dingemans sold 8,360 shares for 1,312.36p each, collecting a total of £109,713.30, and outgoing president of research and development Patrick Vallance dropped 20,322 ordinary shares at 1,317.60p for a grand total of ...Den vollständigen Artikel lesen ...